Literature DB >> 11279079

p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.

T Yakovleva1, A Pramanik, T Kawasaki, K Tan-No, I Gileva, H Lindegren, U Langel, T J Ekstrom, R Rigler, L Terenius, G Bakalkin.   

Abstract

The p53 transcription factor is either latent or activated through multi-site phosphorylation and acetylation of the negative regulatory region in its C-terminal domain (CTD). How CTD modifications activate p53 binding to target DNA sequences via its core domain is still unknown. It has been proposed that nonmodified CTD interacts either with the core domain or with DNA preventing binding of the core domain to DNA and that the fragments of the CTD regulatory region activate p53 by interfering with these interactions. We here characterized the sequence and target specificity of p53 activation by CTD fragments, interaction of activating peptides with p53 and target DNA, and interactions of "latent" p53 with DNA by a band shift assay and by fluorescence correlation spectroscopy. In addition to CTD fragments, several long basic peptides activated p53 and also transcription factor YY1. These peptides and CTD aggregated target DNA but apparently did not interact with p53. The potency to aggregate DNA correlated with the ability to activate p53, suggesting that p53 binds to target sequences upon interactions with tightly packed DNA in aggregates. Latent full-length p53 dissociated DNA aggregates via its core and CTD, and this effect was potentiated by GTP. Latent p53 also formed complexes via both its core and CTD with long nontarget DNA molecules. Such p53-DNA interactions may occur if latent p53 binding to DNA via CTD prevents the interaction of the core domain with target DNA sites but not with nonspecific DNA sequences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279079     DOI: 10.1074/jbc.M100482200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Role of tumor suppressor p53 domains in selective binding to supercoiled DNA.

Authors:  Marie Brázdová; Jan Palecek; Dmitry I Cherny; Sabina Billová; Miroslav Fojta; Petr Pecinka; Borivoj Vojtesek; Thomas M Jovin; Emil Palecek
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

2.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 3.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

4.  Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.

Authors:  Petr Muller; Juliana M Chan; Oliver Simoncik; Miroslav Fojta; David P Lane; Ted Hupp; Borivoj Vojtesek
Journal:  Protein Sci       Date:  2017-12-08       Impact factor: 6.725

5.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

6.  Dynorphin A (1-17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation.

Authors:  I N Singh; R J Goody; S M Goebel; K M Martin; P E Knapp; Z Marinova; D Hirschberg; T Yakovleva; T Bergman; G Bakalkin; K F Hauser
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

7.  Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.

Authors:  Sárka Pospísilová; Václav Brázda; Katerina Kucharíková; M Gloria Luciani; Ted R Hupp; Petr Skládal; Emil Palecek; Borivoj Vojtesek
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

8.  Mutant p53 proteins bind DNA in a DNA structure-selective mode.

Authors:  Thomas Göhler; Stefan Jäger; Gabriele Warnecke; Hideyo Yasuda; Ella Kim; Wolfgang Deppert
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

9.  Rational design using sequence information only produces a peptide that binds to the intrinsically disordered region of p53.

Authors:  Kiyoto Kamagata; Eriko Mano; Yuji Itoh; Takuro Wakamoto; Ryo Kitahara; Saori Kanbayashi; Hiroto Takahashi; Agato Murata; Tomoshi Kameda
Journal:  Sci Rep       Date:  2019-06-28       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.